TUBA1B and central nervous system cancer: This analysis across multiple cancers revealed significant correlations between TUBA1B expression and promoter methylation in nine tumor types, with ovarian cancer (OV) showing the highest positive and lower-grade gliomas (LGG) the highest negative correlation (Figure 5E).